A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy

被引：0
|
作者：
Ciezki, J [1 ]
Klein, E [1 ]
Angermeier, K [1 ]
Ulchaker, J [1 ]
Mahadevan, A [1 ]
Reddy, C [1 ]
机构：
[1] Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH 44195 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
43
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer
    Goy, Barry W.
    Burchette, Raoul
    Soper, Margaret S.
    Chang, Tangel
    Cosmatos, Harry A.
    UROLOGY, 2020, 136 : 180 - 188
  • [42] Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer
    Ciezki, Jay P.
    UROLOGY, 2020, 136 : 188 - 189
  • [43] Intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT): A risk group with heterogeneous behavior.
    Perez de la Puente, Constanza
    Losco, Federico
    Chacon, Carolina
    Pablo Sade, Juan
    Giornelli, Gonzalo H.
    Chacon, Matias
    Chacon, Reinaldo D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [44] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Faria, Sergio
    Dal Pra, Alan
    Cury, Fabio
    David, Marc
    Duclos, Marie
    Freeman, Carolyn R.
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (03) : 486 - 489
  • [45] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Dal Pra, A.
    Faria, S.
    Cury, F. L.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [46] Patients' Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer
    De, Brian
    Lowenstein, Lisa M.
    Corrigan, Kelsey L.
    Andring, Lauren M.
    Kuban, Deborah A.
    Cantor, Scott B.
    Volk, Robert J.
    Hoffman, Karen E.
    MDM POLICY & PRACTICE, 2022, 7 (02)
  • [47] Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?
    Takagi, M.
    Demizu, Y.
    Fuwa, N.
    Sulaiman, N. S.
    Jin, D.
    Terashima, K.
    Fujii, O.
    Nagano, F.
    Waki, T.
    Mima, M.
    Niwa, Y.
    Katsui, K.
    Murakami, M.
    Okimoto, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E263 - E263
  • [48] Androgen Deprivation Therapy in Patients Treated with External Beam Radiotherapy for High-risk Prostate Cancer in the PSA Era
    Vassil, A. D.
    Murphy, E. S.
    Robinson, C. G.
    Reddy, C. A.
    Chehade, N.
    Ciezki, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S82 - S82
  • [49] Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation
    Fitch, Dwight L.
    McGrath, Samuel
    Martinez, Alvaro A.
    Vicini, Frank A.
    Kestin, Larry L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1430 - 1439
  • [50] Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience
    Delouya, Guila
    Lambert, Carole
    Bahary, Jean-Paul
    Beauchemin, Marie-Claude
    Barkati, Maroie
    Menard, Cynthia
    Taussky, Daniel
    CANADIAN JOURNAL OF UROLOGY, 2017, 24 (03) : 8822 - 8826
12345